Soleno Therapeutics News

Soleno Therapeutics | 8-K: Current report

Jun 6 16:33 ET

Soleno Therapeutics | 8-K: Soleno Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results

May 10 14:57 ET

Soleno Therapeutics | 8-K: Current report

May 7 17:31 ET

Soleno Therapeutics | 8-K: Current report

Apr 29 16:13 ET

Soleno Therapeutics | DEF 14A: Definitive information statements

Apr 22 16:32 ET

Soleno Therapeutics | 8-K: Current report

Apr 22 16:17 ET

Soleno Therapeutics | 8-K: Soleno Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2023 Financial Results

Mar 7 06:09 ET

Soleno Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Jan 31 16:24 ET

Soleno Therapeutics | 8-K: Current report

Jan 30 16:59 ET

Soleno Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Jan 17 00:00 ET

Soleno Therapeutics | 8-K: Current report

Jan 5 00:00 ET

Soleno Therapeutics | S-3ASR: Automatic shelf registration statement of securities of well-known seasoned issuers

Jan 2 00:00 ET

Soleno Therapeutics | S-3: Registration statement for specified transactions by certain issuers

Oct 20, 2023 16:32 ET

Soleno Therapeutics | 8-K: Current report

Sep 29, 2023 16:55 ET

Soleno Therapeutics | 8-K: Current report

Sep 27, 2023 17:23 ET

Soleno Therapeutics | 8-K: Current report

Sep 26, 2023 07:30 ET

Soleno Therapeutics | 8-K: Current report

Aug 16, 2023 09:00 ET

Soleno Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Aug 8, 2023 17:25 ET

Soleno Therapeutics | 8-K: Soleno Therapeutics Provides Corporate Update and Reports Second Quarter 2023 Financial Results

Aug 8, 2023 16:25 ET

Soleno Therapeutics | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)

Jul 28, 2023 16:31 ET